Ordentlich Peter
- SEC CIK
- 0001594274
No open-market purchases or sales filed in the past year.
Current role at each company
- SNDX Syndax Pharmaceuticals IncChief Scientific Officeras of Feb 17, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ordentlich Peter as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 17, 2023 (view filing) | Feb 15 | 2 days | Ordentlich PeterChief Scientific Officer | SSale | −25.0K | $25.84 | −$646.0K | −100.0%0 after | 2 lots |
| Feb 3, 2023 (view filing) | Feb 1 | 2 days | Ordentlich PeterChief Scientific Officer | SSale | −69 | $28.43 | −$1.96K | −100.0%0 after | |
| Dec 2, 2022 (view filing) | Dec 1-2 | 1 day | Ordentlich PeterChief Scientific Officer | SSale | −25.0K | $25.04 | −$625.9K | −99.0%265 after | 3 lots |
| Aug 26, 2022 (view filing) | Aug 24 | 2 days | Ordentlich PeterChief Scientific Officer | SSale | −25.0K | $25.04 | −$626.0K | −99.0%265 after | 2 lots |
| Feb 3, 2022 (view filing) | Feb 1 | 2 days | Ordentlich PeterChief Scientific Officer | SSale | −1.41K | $16.65 | −$23.5K | −100.0%0 after |